Folgen
Prof. Dr. Falk Nimmerjahn
Prof. Dr. Falk Nimmerjahn
Professor for Genetics, FAU Erlangen-Nürnberg
Bestätigte E-Mail-Adresse bei fau.de
Titel
Zitiert von
Zitiert von
Jahr
Fcγ receptors as regulators of immune responses
F Nimmerjahn, JV Ravetch
Nature Reviews Immunology 8 (1), 34-47, 2008
28602008
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Y Kaneko, F Nimmerjahn, JV Ravetch
science 313 (5787), 670-673, 2006
18582006
Fcγ receptors: old friends and new family members
F Nimmerjahn, JV Ravetch
Immunity 24 (1), 19-28, 2006
12872006
Divergent immunoglobulin g subclass activity through selective Fc receptor binding
F Nimmerjahn, JV Ravetch
Science 310 (5753), 1510-1512, 2005
11412005
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc
RM Anthony, F Nimmerjahn, DJ Ashline, VN Reinhold, JC Paulson, ...
Science, 2008
8552008
FcγRIV: a novel FcR with distinct IgG subclass specificity
F Nimmerjahn, P Bruhns, K Horiuchi, JV Ravetch
Immunity 23 (1), 41-51, 2005
8032005
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
I Schwab, F Nimmerjahn
Nature Reviews Immunology 13 (3), 176-189, 2013
7262013
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
U Harre, D Georgess, H Bang, A Bozec, R Axmann, E Ossipova, ...
The Journal of clinical investigation 122 (5), 1791-1802, 2012
7252012
Anti-inflammatory actions of intravenous immunoglobulin
F Nimmerjahn, JV Ravetch
Annu. Rev. Immunol. 26, 513-533, 2008
6102008
Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate
H Schoenen, B Bodendorfer, K Hitchens, S Manzanero, K Werninghaus, ...
The Journal of Immunology 184 (6), 2756-2760, 2010
4702010
Fc‐receptors as regulators of immunity
F Nimmerjahn, JV Ravetch
Advances in immunology 96, 179-204, 2007
4682007
Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1
CM Karsten, MK Pandey, J Figge, R Kilchenstein, PR Taylor, M Rosas, ...
Nature medicine 18 (9), 1401-1406, 2012
4102012
Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy
F Nimmerjahn, S Milosevic, U Behrends, EM Jaffee, DM Pardoll, ...
European journal of immunology 33 (5), 1250-1259, 2003
3632003
The antiinflammatory activity of IgG: the intravenous IgG paradox
F Nimmerjahn, JV Ravetch
The Journal of experimental medicine 204 (1), 11-15, 2007
3322007
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation
K Werninghaus, A Babiak, O Groß, C Hölscher, H Dietrich, EM Agger, ...
Journal of Experimental Medicine 206 (1), 89-97, 2009
3252009
Antibodies, Fc receptors and cancer
F Nimmerjahn, JV Ravetch
Current opinion in immunology 19 (2), 239-245, 2007
3002007
Antibody‐mediated modulation of immune responses
F Nimmerjahn, JV Ravetch
Immunological reviews 236 (1), 265-275, 2010
2952010
Mechanisms of autoantibody-induced pathology
RJ Ludwig, K Vanhoorelbeke, F Leypoldt, Z Kaya, K Bieber, ...
Frontiers in immunology, 603, 2017
2862017
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
F Nimmerjahn, RM Anthony, JV Ravetch
Proceedings of the National Academy of Sciences 104 (20), 8433-8437, 2007
2812007
Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy
Y Hamaguchi, Y Xiu, K Komura, F Nimmerjahn, TF Tedder
The Journal of experimental medicine 203 (3), 743-753, 2006
2712006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20